A Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer
Clinical trial NCT07031154 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07031154
- Sponsor
- The First Affiliated Hospital of Xiamen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-30
- Primary completion
- 2027-02-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.